内科におけるオピオイド誘発性便秘:認識と管理方法
Piero Portincasa1, Chiara Valentina Luglio2, Silvia Sozzi2
1Division of Internal Medicine 'A. Murri' and Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari 'Aldo Moro', Bari, Italy. piero.portincasa@uniba.it.
Internal and emergency medicine
|August 28, 2025
まとめ
オピオイド誘発性便秘 (OIC) はオピオイド療法の一般的な副作用です. 新しい7段階の経路により OICの診断と管理が改善され 患者の生活の質が向上します
科学分野:
- 胃腸内科
- 内科 医学
- 薬理学について
背景:
- オピオイド誘発性便秘 (OIC) は,慢性的なオピオイド治療を受けている患者において,流行し,苦痛を与える胃腸の副作用です.
- OICはしばしば診断が不十分で 治療が不適切であり 患者の生活の質に重大な影響を及ぼします
- 内科におけるOICに対する意識を高め,アプローチを標準化する必要がある.
研究 の 目的:
- 内科におけるOICの認識を高めるため
- OICの診断と管理のための欧州の専門家ガイドライン (ECHO OIC) を見直し,調整する.
- イタリアの専門家のコンセンサスを通じて,国内でのカスタマイズと多学科的アプローチを提供すること.
主な方法:
- オピオイド誘発性便秘 (ECHO OIC) の医療成果の改善に関する調査
- イタリアの専門家のコンセンサスグループによるガイドラインの議論と調整
- OICのための多段階の臨床経路の実施
主要な成果:
- OICの予防,診断,治療,長期的な管理のための7段階の診断治療法が策定されました.
- この経路では,教育,早期介入,モニタリング,適応された薬理学的戦略,調整された紹介が強調されています.
- このアプローチは,OICを患っている患者の生活の質を改善することを目的としています.
結論:
- OICに対する意識の向上は,臨床実務において極めて重要です.
- ECHO OICの7段階の経路は,OICの管理を改善するための実用的で拡張可能なモデルを提供します.
- 効果的なOICのケアには 多分野にまたがったアプローチが不可欠です
さらに関連する動画
関連する概念動画
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
323
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
323
Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292
Opioid Analgesics: Morphine and Other Natural Cogeners
361
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
Drugs for Treatment of Constipation-Predominant IBS
326
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
326


